Elucidating the impact of the pneumococcal conjugate vaccine programme on pneumonia, sepsis and otitis media hospital admissions in England using a composite control

BACKGROUND: The seven-valent pneumococcal conjugate vaccine (PCV) was introduced in England in September 2006, changing to the 13-valent vaccine in April 2010. PCV impact on invasive pneumococcal disease (IPD) has been extensively reported, but less described is its impact on the burden of pneumonia...

Descripción completa

Detalles Bibliográficos
Autores principales: Thorrington, Dominic, Andrews, Nick, Stowe, Julia, Miller, Elizabeth, van Hoek, Albert Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5804014/
https://www.ncbi.nlm.nih.gov/pubmed/29415741
http://dx.doi.org/10.1186/s12916-018-1004-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5804014/
https://www.ncbi.nlm.nih.gov/pubmed/29415741
http://dx.doi.org/10.1186/s12916-018-1004-z

Ejemplares similares